BEZ235, a dual inhibitor of PI3K and mTOR inhibits the adipocyte-derived CM-mediated breast cancer progression. We then confirmed whether the PI3K-AKT-mTOR pathway is involved in the adipocyte-derived CM-induced cell proliferation. This evidence concerns the gene AKT1 and breast carcinoma.